This inventor holds 11 USPTO granted patents and 4 published patent applications, plus 12 CIPO patents and 17 EPO patents. Top assignees: Geneohm Sciences Canada, Inc., Geneohm Sciences, Inc., Genohm Sciences Canada, Inc.. Active years: 2008-2023.
Location History:
- Quebec, CA (2012)
- Sillery, CA (2008 - 2020)
- Québec, CA (2013 - 2023)
Company Filing History:
7 out of 20 
2 out of 14 
1 out of 1 
Years Active: 2008-2023
Title: Ann Huletsky: Innovator in Methicillin-Resistant Staphylococcus Aureus Detection
Introduction
Ann Huletsky is a prominent inventor based in Sillery, CA, known for her significant contributions to the field of microbiology, particularly in the detection of methicillin-resistant Staphylococcus aureus (MRSA). With a total of 11 patents to her name, her work has had a substantial impact on diagnostic methods and epidemiological studies.
Latest Patents
Among her latest patents, Huletsky has developed innovative sequences for the detection and identification of methicillin-resistant strains. One of her notable inventions is titled "Sequences for detection and identification of methicillin-resistant (MRSA) of MREJ types xi to xx." This patent describes novel SCCmec right extremity junction (MREJ) sequences that facilitate the specific detection of MRSA for diagnostic purposes. Another significant patent is "Method for the detection and identification of methicillin-resistant," which outlines the use of these DNA sequences for effective diagnostic applications.
Career Highlights
Throughout her career, Ann Huletsky has worked with reputable organizations, including Geneohm Sciences Canada, Inc. and Geneohm Sciences, Inc. Her expertise in molecular diagnostics has positioned her as a leader in her field, contributing to advancements in public health and safety.
Collaborations
She has collaborated with esteemed colleagues such as Valery Rossbach and Michel G Bergeron, further enhancing her research and development efforts in the detection of antibiotic-resistant bacteria.
Conclusion
Ann Huletsky's innovative work in the detection of methicillin-resistant Staphylococcus aureus has made her a key figure in microbiology. Her patents and collaborations reflect her commitment to improving diagnostic methods and public health outcomes.